Wilson A - Search Results

1

A community of practice approach to bioanalysis delivery: the role of the Preclinical Bioanalysis and Toxicokinetics department at AstraZeneca.

Wilson A, Silvester S, Woods K. Wilson A, et al. Bioanalysis. 2014 May;6(10):1329-37. doi: 10.4155/bio.14.106. Bioanalysis. 2014. PMID: 24958117

2

Bioanalytical implementation of plasma capillary microsampling: small hurdles, large gains.

Spreadborough MJ, Day J, Jackson-Addie K, Wilson A. Spreadborough MJ, et al. Among authors: wilson a. Bioanalysis. 2013 Jun;5(12):1485-9. doi: 10.4155/bio.13.120. Bioanalysis. 2013. PMID: 23795926 No abstract available.

3

Issues facing the bioanalytical community: summary of round table discussions.

Spooner N, Cape S, Hayes R, Kaur S, Kolman J, Lowes S, Summerfield S, Wilson A, Woolf E. Spooner N, et al. Among authors: wilson a. Bioanalysis. 2016 Nov;8(21):2189-2193. doi: 10.4155/bio-2016-4993. Epub 2016 Sep 19. Bioanalysis. 2016. PMID: 27642800 No abstract available.

4

Changing shape: evolving an outsourced bioanalytical strategy to support the changing needs of drug development.

Stovold C, Milligan F, Hawthorne G, Pattison C, Wilson A. Stovold C, et al. Among authors: wilson a. Bioanalysis. 2017 Aug;9(15):1135-1137. doi: 10.4155/bio-2017-0098. Epub 2017 Aug 1. Bioanalysis. 2017. PMID: 28763237 No abstract available.

5

Cationic lipid bioanalysis: understanding distribution of lipid nanoparticles for delivery of RNA therapeutics.

Hawthorne G, Harbach S, Wilson A. Hawthorne G, et al. Among authors: wilson a. Bioanalysis. 2018 Mar 1;10(5):275-277. doi: 10.4155/bio-2017-0279. Epub 2018 Mar 1. Bioanalysis. 2018. PMID: 29494232 Free article. No abstract available.

6

The business of bioanalysis: summary of panel discussions.

Spooner N, Beaver C, Kolman J, Summerfield S, Thomas L, Verhaeghe T, Wilson A. Spooner N, et al. Among authors: wilson a. Bioanalysis. 2018 Aug 1;10(15):1169-1175. doi: 10.4155/bio-2018-0153. Epub 2018 Jul 23. Bioanalysis. 2018. PMID: 30033746 No abstract available.

7

Incurred sample reanalysis in AstraZeneca small molecule portfolio - what have we learned and where do we go next?

Arfvidsson C, Wilson A, Heijer M, Bailey C, Severin P, Milligan F, Ngeny M, Dayton B, Li Y, Cape S. Arfvidsson C, et al. Among authors: wilson a. Bioanalysis. 2018 Nov 1;10(21):1733-1745. doi: 10.4155/bio-2018-0162. Epub 2018 Oct 16. Bioanalysis. 2018. PMID: 30325197

8

European Bioanalysis Forum recommendation on the best practices to demonstrate processed sample stability.

Wilson A, Barker S, Freisleben A, Laakso S, Staelens L, White S, Timmerman P. Wilson A, et al. Bioanalysis. 2019 Jan;11(1):7-11. doi: 10.4155/bio-2018-0271. Epub 2018 Nov 26. Bioanalysis. 2019. PMID: 30475068

9

Bioanalysis - but not as we knew it: an AstraZeneca perspective of the last 10 years evolution to meet a diversifying portfolio.

Hawthorne G, Henderson N, Hölttä M, Stovold C, Wåhlander Å, Wilson A. Hawthorne G, et al. Among authors: wilson a. Bioanalysis. 2019 Apr;11(7):595-599. doi: 10.4155/bio-2019-0037. Epub 2019 Apr 18. Bioanalysis. 2019. PMID: 30997810 No abstract available.

10

Overcoming analytical challenges to generate data critical to understanding lipid nanoparticle-delivered modified mRNA biodistribution.

Hawthorne G, Henderson N, Hölttä M, Khan S, Lindqvist J, Wilson A. Hawthorne G, et al. Among authors: wilson a. Bioanalysis. 2019 Nov;11(21):1993-2001. doi: 10.4155/bio-2019-0138. Epub 2019 Oct 16. Bioanalysis. 2019. PMID: 31617402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,228 results

Search Page

Filters